79 related articles for article (PubMed ID: 24642511)
1. Progressive Multifocal Leukoencephalopathy and Monoclonal Antibodies: A Review.
Bohra C; Sokol L; Dalia S
Cancer Control; 2017; 24(4):1073274817729901. PubMed ID: 28975841
[TBL] [Abstract][Full Text] [Related]
2. Progressive multifocal leukoencephalopathy after fingolimod treatment.
Berger JR; Cree BA; Greenberg B; Hemmer B; Ward BJ; Dong VM; Merschhemke M
Neurology; 2018 May; 90(20):e1815-e1821. PubMed ID: 29669908
[TBL] [Abstract][Full Text] [Related]
3. Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?
Clerico M; De Mercanti SF; Signori A; Iudicello M; Cordioli C; Signoriello E; Lus G; Bonavita S; Lavorgna L; Maniscalco GT; Curti E; Lorefice L; Cocco E; Nociti V; Mirabella M; Baroncini D; Mataluni G; Landi D; Petruzzo M; Lanzillo R; Gandoglia I; Laroni A; Frangiamore R; Sartori A; Cavalla P; Costantini G; Sormani MP; Capra R
Neurotherapeutics; 2020 Jan; 17(1):200-207. PubMed ID: 31452081
[TBL] [Abstract][Full Text] [Related]
4. Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy in China.
Fan S; Liu M; Bai L; Chen S; Hou B; Lin N; Yuan J; Mao C; Niu J; Ren H; Zhao Y; Zhang Z; Zhu Y; Peng B; Guan H
J Neurovirol; 2023 Dec; 29(6):692-698. PubMed ID: 37898569
[TBL] [Abstract][Full Text] [Related]
5. Progressive multifocal leukoencephalopathy with hypointense halo on MRI.
Braga VL; Sarmento FP; Fraiman P; Bichuetti DB; Ferraz HB; Oliveira EML
Pract Neurol; 2024 Jan; 24(1):78-79. PubMed ID: 37604682
[No Abstract] [Full Text] [Related]
6. The Connecting Link: A Case Report of the First Association of COVID-19 and Progressive Multifocal Leukoencephalopathy.
Varghese N; Dhar D; Mukherjee A; Nashi S; Nandeesh BN; Kulkarni GB; Taallapalli AVR; Alladi S
Ann Indian Acad Neurol; 2023; 26(6):1028-1030. PubMed ID: 38229649
[No Abstract] [Full Text] [Related]
7. "Shrimp Sign" in Progressive Multifocal Leukoencephalopathy.
Agarwal A; Garg D; Garg A; Srivastava AK
Ann Indian Acad Neurol; 2024; 27(1):82-83. PubMed ID: 38495251
[No Abstract] [Full Text] [Related]
8. Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI.
Wattjes MP; Barkhof F
Curr Opin Neurol; 2014 Jun; 27(3):260-70. PubMed ID: 24739400
[TBL] [Abstract][Full Text] [Related]
9. Progressive Multifocal Leukoencephalopathy in the Absence of Typical Radiological Changes: Can We Make a Diagnosis?
AlTahan AM; Berger T; AlOrainy IA; AlTahan H
Am J Case Rep; 2019 Jan; 20():101-105. PubMed ID: 30674865
[TBL] [Abstract][Full Text] [Related]
10. Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.
Maas RP; Muller-Hansma AH; Esselink RA; Murk JL; Warnke C; Killestein J; Wattjes MP
J Neurol; 2016 Oct; 263(10):2004-21. PubMed ID: 27401179
[TBL] [Abstract][Full Text] [Related]
11. Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities.
Honce JM; Nagae L; Nyberg E
Mult Scler Int; 2015; 2015():809252. PubMed ID: 26483978
[TBL] [Abstract][Full Text] [Related]
12. Presumptive progressive multifocal leukoencephalopathy in multiple sclerosis after natalizumab therapy.
Eisele P; Szabo K; Hornberger E; Griebe M; Hennerici MG; Kieseier BC; Gass A
J Neuroimaging; 2014; 24(4):425-8. PubMed ID: 23323645
[TBL] [Abstract][Full Text] [Related]
13. Review of progressive multifocal leukoencephalopathy and natalizumab.
Aksamit AJ
Neurologist; 2006 Nov; 12(6):293-8. PubMed ID: 17122725
[TBL] [Abstract][Full Text] [Related]
14. Transient punctuate enhancing lesions preceding natalizumab-associated progressive multifocal leukoencephalopathy.
Taieb G; Renard D; Thouvenot E; Servillo G; Castelnovo G
J Neurol Sci; 2014 Nov; 346(1-2):364-5. PubMed ID: 25241939
[No Abstract] [Full Text] [Related]
15. Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab.
Sørensen PS; Bertolotto A; Edan G; Giovannoni G; Gold R; Havrdova E; Kappos L; Kieseier BC; Montalban X; Olsson T
Mult Scler; 2012 Feb; 18(2):143-52. PubMed ID: 22312009
[TBL] [Abstract][Full Text] [Related]
16. Atypical MRI features at early onset natalizumab-associated progressive multifocal leukoencephalopathy: a case report.
Piola M; Di Palma F; Mascoli N; Binda S; Arnaboldi M; Rezzonico M
J Neurol Sci; 2014 May; 340(1-2):213-4. PubMed ID: 24642511
[TBL] [Abstract][Full Text] [Related]
17. The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy.
Wattjes MP; Richert ND; Killestein J; de Vos M; Sanchez E; Snaebjornsson P; Cadavid D; Barkhof F
Mult Scler; 2013 Dec; 19(14):1826-40. PubMed ID: 24192217
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
